These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1875451)

  • 21. Very-low-density lipoprotein-induced triglyceride accumulation in human mesangial cells is mainly mediated by lipoprotein lipase.
    Li J; Li H; Wen YB; Li XW
    Nephron Physiol; 2008; 110(1):p1-10. PubMed ID: 18698144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoprotein lipase increases low density lipoprotein retention by subendothelial cell matrix.
    Saxena U; Klein MG; Vanni TM; Goldberg IJ
    J Clin Invest; 1992 Feb; 89(2):373-80. PubMed ID: 1737833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholesteryl ester accumulation in mouse peritoneal macrophages induced by beta-migrating very low density lipoproteins from patients with atypical dysbetalipoproteinemia.
    Bersot TP; Innerarity TL; Mahley RW; Havel RJ
    J Clin Invest; 1983 Sep; 72(3):1024-33. PubMed ID: 6309903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidized VLDL induces less triglyceride accumulation in J774 macrophages than native VLDL due to an impaired extracellular lipolysis.
    Jong MC; Hendriks WL; van Vark LC; Dahlmans VE; Groener JE; Havekes LM
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):144-51. PubMed ID: 10634811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.
    Sun HY; Lin CC; Lee JC; Wang SW; Cheng PN; Wu IC; Chang TT; Lai MD; Shieh DB; Young KC
    Gut; 2013 Aug; 62(8):1193-203. PubMed ID: 22689516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utilisation of fatty acid and triacylglycerol by rat macrophages: the effect of endotoxin.
    Hauton D; Evans RD
    Cell Physiol Biochem; 2002; 12(5-6):293-304. PubMed ID: 12438765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of lipoprotein lipase induced cholesterol ester accumulation in human hepatoma HepG2 cells.
    Cianflone K; Avramoglu RK; Sawyez C; Huff MW
    Atherosclerosis; 1996 Feb; 120(1-2):101-14. PubMed ID: 8645351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The LDL receptor is the major pathway for beta-VLDL uptake by mouse peritoneal macrophages.
    Perrey S; Ishibashi S; Kitamine T; Osuga J; Yagyu H; Chen Z; Shionoiri F; Iizuka Y; Yahagi N; Tamura Y; Ohashi K; Harada K; Gotoda T; Yamada N
    Atherosclerosis; 2001 Jan; 154(1):51-60. PubMed ID: 11137082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipoprotein metabolism during acute inhibition of lipoprotein lipase in the cynomolgus monkey.
    Goldberg IJ; Le NA; Ginsberg HN; Krauss RM; Lindgren FT
    J Clin Invest; 1988 Feb; 81(2):561-8. PubMed ID: 3276735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor-beta1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants.
    Argmann CA; Van Den Diepstraten CH; Sawyez CG; Edwards JY; Hegele RA; Wolfe BM; Huff MW
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):2011-8. PubMed ID: 11742878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ; Breckenridge WC
    Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein lipase stimulates the binding and uptake of moderately oxidized low-density lipoprotein by J774 macrophages.
    Hendriks WL; van der Boom H; van Vark LC; Havekes LM
    Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):563-8. PubMed ID: 8670071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heparan sulphate proteoglycans are involved in the lipoprotein lipase-mediated enhancement of the cellular binding of very low density and low density lipoproteins.
    Mulder M; Lombardi P; Jansen H; van Berkel TJ; Frants RR; Havekes LM
    Biochem Biophys Res Commun; 1992 Jun; 185(2):582-7. PubMed ID: 1610351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct murine macrophage receptor pathway for human triglyceride-rich lipoproteins.
    Gianturco SH; Lin AH; Hwang SL; Young J; Brown SA; Via DP; Bradley WA
    J Clin Invest; 1988 Nov; 82(5):1633-43. PubMed ID: 3183059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Receptor-mediated lipoprotein uptake by human glomerular cells: comparison with skin fibroblasts and HepG2 cells.
    Quaschning T; Königer M; Krämer-Guth A; Greiber S; Pavenstädt H; Nauck M; Schollmeyer P; Wanner C
    Nephrol Dial Transplant; 1997 Dec; 12(12):2528-36. PubMed ID: 9430847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
    Chung BH; Segrest JP; Franklin F
    Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FABP4 inhibition suppresses PPARγ activity and VLDL-induced foam cell formation in IL-4-polarized human macrophages.
    Boss M; Kemmerer M; Brüne B; Namgaladze D
    Atherosclerosis; 2015 Jun; 240(2):424-30. PubMed ID: 25897794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding.
    de Man FH; de Beer F; van der Laarse A; Jansen H; Leuven JA; Souverijn JH; Vroom TF; Schoormans SC; Fruchart JC; Havekes LM; Smelt AH
    Atherosclerosis; 2000 Dec; 153(2):363-71. PubMed ID: 11164425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apo E-mediated uptake and degradation of normal very low density lipoproteins by human monocyte/macrophages: a saturable pathway distinct from the LDL receptor.
    Wang-Iverson P; Ginsberg HN; Peteanu LA; Le NA; Brown WV
    Biochem Biophys Res Commun; 1985 Jan; 126(1):578-86. PubMed ID: 3970709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipolysis produces changes in the immunoreactivity and cell reactivity of very low density lipoproteins.
    Schonfeld G; Patsch W; Pfleger B; Witztum JL; Weidman SW
    J Clin Invest; 1979 Nov; 64(5):1288-97. PubMed ID: 227930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.